Search Tag: cancer
2025 15 Oct
Non-communicable diseases (NCDs) remain the leading cause of death worldwide, and tracking mortality changes over time is central to policy and planning. Using the unconditional probability of dying from an NCD between birth and age 80 years, an analysis across 185 countries shows widespread declines through 2010–2019 yet momentum weakened compared...Read more
2024 03 Dec
Radiological imaging is a crucial tool for monitoring disease progression and evaluating the effectiveness of treatments over time. By capturing images at different time points, clinicians gain critical insights into changes such as tumour growth, lesion development or responses to therapy. However, comparing these images poses significant challenges...Read more
2023 09 May
As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives. We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more
2023 09 May
As a leader in women’s health, Hologic knows that increasing access to breast cancer screening is critical to detecting cancer earlier and saving lives. We commend the U.S. Preventive Services Task Force (USPSTF) for changing their draft guidelines to recommend that women begin screening at age 40. Lowering the age for initial screening to 40...Read more
2022 01 Mar
Innovative rhPSMA Theranostic technology has the potential to offer both diagnostic imaging and treatment for patients affected by prostate cancer. Blue Earth Therapeutics has exclusive worldwide rights to therapeutic applications of radiohybrid Prostate-Specific Membrane Antigen (rhPSMA) radiopharmaceutical technology. “ We are increasingly...Read more
2021 30 Nov
When Prof. James Brenton was seeing one of his patients at Addenbrooke’s Hospital recently for ovarian cancer treatment, he needed to review all her studies and treatments. The information was complex and lengthy: blood test results, genomic tests, imaging studies and reports from past therapy. Brenton hadn’t been able to attend the tumor board meeting...Read more
2017 16 Sep
Hologic, Inc. is deeply concerned that the United States Preventive Services Task Force (USPSTF) did not include a grade for co-testing (also known as Pap+HPV Together) in draft cervical cancer screening recommendations released this week. These draft recommendations do not consider the wealth of data supporting the value of co-testing, and will put...Read more
2017 07 Jun
I was struck by a press announcement of the United States Food and Drug Administration of 23 May 2017: ‘ FDA approves first cancer treatment for any solid tumour with a specific genetic feature ’ This is good news. Because it means that the knowledge that science has given us many years ago now is accepted by the regulator for the first time....Read more
2016 04 Dec
According to Mayo Clinic researchers, 10 percent of all patients who come to the hospital with the most severe type of heart attack have a history of cancer. They also found that this emerging subgroup of heart patients has a three times higher risk of noncardiac death. The findings are published in Mayo Clinic Proceedings. See Also : Cardio-Oncology:...Read more
2017 03 Mar
The 11th edition of this symposium, organised by ESMO and GEICO is the ideal environment to discuss both new and standard approaches to the treatment and management of ovarian cancer. Save the date for the 11th International Symposium on Advanced Ovarian Cancer: Optimal Therapy. Update. Read more